These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 23717590)

  • 1. Augmenting transport versus increasing cold storage to improve vaccine supply chains.
    Haidari LA; Connor DL; Wateska AR; Brown ST; Mueller LE; Norman BA; Schmitz MM; Paul P; Rajgopal J; Welling JS; Leonard J; Chen SI; Lee BY
    PLoS One; 2013; 8(5):e64303. PubMed ID: 23717590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Only adding stationary storage to vaccine supply chains may create and worsen transport bottlenecks.
    Haidari LA; Connor DL; Wateska AR; Brown ST; Mueller LE; Norman BA; Schmitz MM; Paul P; Rajgopal J; Welling JS; Leonard J; Claypool EG; Weng YT; Chen SI; Lee BY
    J Public Health Manag Pract; 2013; 19 Suppl 2(0 2):S65-7. PubMed ID: 23903398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of implementing a demand forecasting system into a low-income country's supply chain.
    Mueller LE; Haidari LA; Wateska AR; Phillips RJ; Schmitz MM; Connor DL; Norman BA; Brown ST; Welling JS; Lee BY
    Vaccine; 2016 Jul; 34(32):3663-9. PubMed ID: 27219341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of introducing the pneumococcal and rotavirus vaccines into the routine immunization program in Niger.
    Lee BY; Assi TM; Rajgopal J; Norman BA; Chen SI; Brown ST; Slayton RB; Kone S; Kenea H; Welling JS; Connor DL; Wateska AR; Jana A; Wiringa AE; Van Panhuis WG; Burke DS
    Am J Public Health; 2012 Feb; 102(2):269-76. PubMed ID: 21940923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of making vaccines thermostable in Niger's vaccine supply chain.
    Lee BY; Cakouros BE; Assi TM; Connor DL; Welling J; Kone S; Djibo A; Wateska AR; Pierre L; Brown ST
    Vaccine; 2012 Aug; 30(38):5637-43. PubMed ID: 22789507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Removing the regional level from the Niger vaccine supply chain.
    Assi TM; Brown ST; Kone S; Norman BA; Djibo A; Connor DL; Wateska AR; Rajgopal J; Slayton RB; Lee BY
    Vaccine; 2013 Jun; 31(26):2828-34. PubMed ID: 23602666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maintaining vaccine delivery following the introduction of the rotavirus and pneumococcal vaccines in Thailand.
    Lee BY; Assi TM; Rookkapan K; Wateska AR; Rajgopal J; Sornsrivichai V; Chen SI; Brown ST; Welling J; Norman BA; Connor DL; Bailey RR; Jana A; Van Panhuis WG; Burke DS
    PLoS One; 2011; 6(9):e24673. PubMed ID: 21931805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic impact of thermostable vaccines.
    Lee BY; Wedlock PT; Haidari LA; Elder K; Potet J; Manring R; Connor DL; Spiker ML; Bonner K; Rangarajan A; Hunyh D; Brown ST
    Vaccine; 2017 May; 35(23):3135-3142. PubMed ID: 28455169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of changing the measles vaccine vial size on Niger's vaccine supply chain: a computational model.
    Assi TM; Brown ST; Djibo A; Norman BA; Rajgopal J; Welling JS; Chen SI; Bailey RR; Kone S; Kenea H; Connor DL; Wateska AR; Jana A; Wisniewski SR; Van Panhuis WG; Burke DS; Lee BY
    BMC Public Health; 2011 Jun; 11():425. PubMed ID: 21635774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How much does it cost to get a dose of vaccine to the service delivery location? Empirical evidence from Vietnam's Expanded Program on Immunization.
    Mvundura M; Kien VD; Nga NT; Robertson J; Cuong NV; Tung HT; Hong DT; Levin C
    Vaccine; 2014 Feb; 32(7):834-8. PubMed ID: 24370713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The benefits of redesigning Benin's vaccine supply chain.
    Brown ST; Schreiber B; Cakouros BE; Wateska AR; Dicko HM; Connor DL; Jaillard P; Mvundura M; Norman BA; Levin C; Rajgopal J; Avella M; Lebrun C; Claypool E; Paul P; Lee BY
    Vaccine; 2014 Jul; 32(32):4097-103. PubMed ID: 24814550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How influenza vaccination policy may affect vaccine logistics.
    Assi TM; Rookkapan K; Rajgopal J; Sornsrivichai V; Brown ST; Welling JS; Norman BA; Connor DL; Chen SI; Slayton RB; Laosiritaworn Y; Wateska AR; Wisniewski SR; Lee BY
    Vaccine; 2012 Jun; 30(30):4517-23. PubMed ID: 22537993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potential effects of introducing microneedle patch vaccines into routine vaccine supply chains.
    Wedlock PT; Mitgang EA; Elsheikh F; Leonard J; Bakal J; Welling J; Crawford J; Assy E; Magadzire BP; Bechtel R; DePasse JV; Siegmund SS; Brown ST; Lee BY
    Vaccine; 2019 Jan; 37(4):645-651. PubMed ID: 30578088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Landscaping the structures of GAVI country vaccine supply chains and testing the effects of radical redesign.
    Lee BY; Connor DL; Wateska AR; Norman BA; Rajgopal J; Cakouros BE; Chen SI; Claypool EG; Haidari LA; Karir V; Leonard J; Mueller LE; Paul P; Schmitz MM; Welling JS; Weng YT; Brown ST
    Vaccine; 2015 Aug; 33(36):4451-8. PubMed ID: 26209835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unless changes are made in Benin, multiple storage and transport bottlenecks may prevent vaccines from reaching the population.
    Brown ST; Lee BY
    Vaccine; 2014 May; 32(21):2518-9. PubMed ID: 24582633
    [No Abstract]   [Full Text] [Related]  

  • 16. Re-designing the Mozambique vaccine supply chain to improve access to vaccines.
    Lee BY; Haidari LA; Prosser W; Connor DL; Bechtel R; Dipuve A; Kassim H; Khanlawia B; Brown ST
    Vaccine; 2016 Sep; 34(41):4998-5004. PubMed ID: 27576077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reorganizing Nigeria's Vaccine Supply Chain Reduces Need For Additional Storage Facilities, But More Storage Is Required.
    Shittu E; Harnly M; Whitaker S; Miller R
    Health Aff (Millwood); 2016 Feb; 35(2):293-300. PubMed ID: 26858383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of tailoring vial sizes to populations and locations.
    Wedlock PT; Mitgang EA; Haidari LA; Prosser W; Brown ST; Krudwig K; Siegmund SS; DePasse JV; Bakal J; Leonard J; Welling J; Steinglass R; Mwansa FD; Phiri G; Lee BY
    Vaccine; 2019 Jan; 37(4):637-644. PubMed ID: 30578087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One size does not fit all: The impact of primary vaccine container size on vaccine distribution and delivery.
    Haidari LA; Wahl B; Brown ST; Privor-Dumm L; Wallman-Stokes C; Gorham K; Connor DL; Wateska AR; Schreiber B; Dicko H; Jaillard P; Avella M; Lee BY
    Vaccine; 2015 Jun; 33(28):3242-7. PubMed ID: 25889160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The imperative for stronger vaccine supply and logistics systems.
    Zaffran M; Vandelaer J; Kristensen D; Melgaard B; Yadav P; Antwi-Agyei KO; Lasher H
    Vaccine; 2013 Apr; 31 Suppl 2():B73-80. PubMed ID: 23598495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.